Therefore, our results demonstrated that the MALAT-1 score was strongly correlated with prostate cancer risk in the overall group as well as in the subgroup with PSA=4-10 ng/ml and may serve as a noninvasive biomarker for the detection of PCa in urine. This evidence concerns the gene KLK3 and Familial prostate cancer.